nodes	percent_of_prediction	percent_of_DWPC	metapath
Acenocoumarol—ALB—Fluorouracil—urinary bladder cancer	0.114	0.198	CbGbCtD
Acenocoumarol—CYP3A4—Thiotepa—urinary bladder cancer	0.11	0.191	CbGbCtD
Acenocoumarol—CYP1A2—Fluorouracil—urinary bladder cancer	0.0682	0.118	CbGbCtD
Acenocoumarol—ALB—Methotrexate—urinary bladder cancer	0.0629	0.109	CbGbCtD
Acenocoumarol—CYP2C9—Fluorouracil—urinary bladder cancer	0.0614	0.107	CbGbCtD
Acenocoumarol—CYP1A2—Etoposide—urinary bladder cancer	0.0569	0.0989	CbGbCtD
Acenocoumarol—CYP2C9—Cisplatin—urinary bladder cancer	0.0522	0.0907	CbGbCtD
Acenocoumarol—CYP3A4—Etoposide—urinary bladder cancer	0.0298	0.0518	CbGbCtD
Acenocoumarol—CYP3A4—Doxorubicin—urinary bladder cancer	0.0203	0.0353	CbGbCtD
Acenocoumarol—Dicoumarol—NQO1—urinary bladder cancer	0.0123	0.718	CrCbGaD
Acenocoumarol—CYP2C19—urine—urinary bladder cancer	0.0114	0.134	CbGeAlD
Acenocoumarol—VKORC1—prostate gland—urinary bladder cancer	0.0107	0.126	CbGeAlD
Acenocoumarol—CYP1A2—urine—urinary bladder cancer	0.00928	0.11	CbGeAlD
Acenocoumarol—Skin necrosis—Cisplatin—urinary bladder cancer	0.00926	0.0409	CcSEcCtD
Acenocoumarol—CYP2C9—urine—urinary bladder cancer	0.00881	0.104	CbGeAlD
Acenocoumarol—Ulcer—Mitomycin—urinary bladder cancer	0.00867	0.0383	CcSEcCtD
Acenocoumarol—Skin necrosis—Etoposide—urinary bladder cancer	0.00848	0.0375	CcSEcCtD
Acenocoumarol—VKORC1—renal system—urinary bladder cancer	0.00728	0.0859	CbGeAlD
Acenocoumarol—CYP3A4—urine—urinary bladder cancer	0.00672	0.0793	CbGeAlD
Acenocoumarol—Haematuria—Valrubicin—urinary bladder cancer	0.00635	0.0281	CcSEcCtD
Acenocoumarol—VKORC1—female reproductive system—urinary bladder cancer	0.00583	0.0688	CbGeAlD
Acenocoumarol—ORM1—prostate gland—urinary bladder cancer	0.00578	0.0682	CbGeAlD
Acenocoumarol—Skin necrosis—Methotrexate—urinary bladder cancer	0.00508	0.0225	CcSEcCtD
Acenocoumarol—Flunitrazepam—UGT2B7—urinary bladder cancer	0.00483	0.282	CrCbGaD
Acenocoumarol—Skin necrosis—Epirubicin—urinary bladder cancer	0.00475	0.021	CcSEcCtD
Acenocoumarol—Skin necrosis—Doxorubicin—urinary bladder cancer	0.0044	0.0194	CcSEcCtD
Acenocoumarol—Skin exfoliation—Thiotepa—urinary bladder cancer	0.00394	0.0174	CcSEcCtD
Acenocoumarol—Liver injury—Cisplatin—urinary bladder cancer	0.00384	0.017	CcSEcCtD
Acenocoumarol—Ulcer—Gemcitabine—urinary bladder cancer	0.00367	0.0162	CcSEcCtD
Acenocoumarol—Alopecia—Mitomycin—urinary bladder cancer	0.00364	0.0161	CcSEcCtD
Acenocoumarol—Ulcer—Fluorouracil—urinary bladder cancer	0.00361	0.0159	CcSEcCtD
Acenocoumarol—Appetite absent—Methotrexate—urinary bladder cancer	0.00357	0.0158	CcSEcCtD
Acenocoumarol—Ulcer—Cisplatin—urinary bladder cancer	0.00342	0.0151	CcSEcCtD
Acenocoumarol—VKORC1—lymph node—urinary bladder cancer	0.00341	0.0402	CbGeAlD
Acenocoumarol—Body temperature increased—Valrubicin—urinary bladder cancer	0.00336	0.0148	CcSEcCtD
Acenocoumarol—Skin exfoliation—Gemcitabine—urinary bladder cancer	0.00331	0.0146	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.00324	0.0143	CcSEcCtD
Acenocoumarol—ORM1—female reproductive system—urinary bladder cancer	0.00315	0.0372	CbGeAlD
Acenocoumarol—Ulcer—Etoposide—urinary bladder cancer	0.00313	0.0138	CcSEcCtD
Acenocoumarol—Body temperature increased—Carboplatin—urinary bladder cancer	0.00311	0.0137	CcSEcCtD
Acenocoumarol—Skin exfoliation—Cisplatin—urinary bladder cancer	0.00309	0.0136	CcSEcCtD
Acenocoumarol—Diarrhoea—Valrubicin—urinary bladder cancer	0.00291	0.0128	CcSEcCtD
Acenocoumarol—Skin exfoliation—Etoposide—urinary bladder cancer	0.00283	0.0125	CcSEcCtD
Acenocoumarol—Vomiting—Valrubicin—urinary bladder cancer	0.0027	0.0119	CcSEcCtD
Acenocoumarol—Dermatitis—Valrubicin—urinary bladder cancer	0.00268	0.0118	CcSEcCtD
Acenocoumarol—Decreased appetite—Mitomycin—urinary bladder cancer	0.00254	0.0112	CcSEcCtD
Acenocoumarol—Nausea—Valrubicin—urinary bladder cancer	0.00252	0.0112	CcSEcCtD
Acenocoumarol—Body temperature increased—Mitomycin—urinary bladder cancer	0.00231	0.0102	CcSEcCtD
Acenocoumarol—CYP1A2—renal system—urinary bladder cancer	0.00227	0.0268	CbGeAlD
Acenocoumarol—Haematuria—Thiotepa—urinary bladder cancer	0.0022	0.00973	CcSEcCtD
Acenocoumarol—Haemoglobin—Thiotepa—urinary bladder cancer	0.00208	0.0092	CcSEcCtD
Acenocoumarol—Haemorrhage—Thiotepa—urinary bladder cancer	0.00207	0.00916	CcSEcCtD
Acenocoumarol—CYP2C19—vagina—urinary bladder cancer	0.00201	0.0238	CbGeAlD
Acenocoumarol—Diarrhoea—Mitomycin—urinary bladder cancer	0.002	0.00885	CcSEcCtD
Acenocoumarol—Liver injury—Epirubicin—urinary bladder cancer	0.00197	0.00872	CcSEcCtD
Acenocoumarol—Ulcer—Methotrexate—urinary bladder cancer	0.00188	0.00829	CcSEcCtD
Acenocoumarol—Vomiting—Mitomycin—urinary bladder cancer	0.00186	0.00822	CcSEcCtD
Acenocoumarol—Haematuria—Gemcitabine—urinary bladder cancer	0.00185	0.00818	CcSEcCtD
Acenocoumarol—ORM1—lymph node—urinary bladder cancer	0.00184	0.0218	CbGeAlD
Acenocoumarol—Dermatitis—Mitomycin—urinary bladder cancer	0.00184	0.00815	CcSEcCtD
Acenocoumarol—Alopecia—Thiotepa—urinary bladder cancer	0.00183	0.00809	CcSEcCtD
Acenocoumarol—Liver injury—Doxorubicin—urinary bladder cancer	0.00183	0.00807	CcSEcCtD
Acenocoumarol—Ulcer—Epirubicin—urinary bladder cancer	0.00176	0.00776	CcSEcCtD
Acenocoumarol—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00175	0.00774	CcSEcCtD
Acenocoumarol—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00174	0.0077	CcSEcCtD
Acenocoumarol—Nausea—Mitomycin—urinary bladder cancer	0.00174	0.00768	CcSEcCtD
Acenocoumarol—Melaena—Methotrexate—urinary bladder cancer	0.00173	0.00766	CcSEcCtD
Acenocoumarol—CYP2C9—female reproductive system—urinary bladder cancer	0.00173	0.0204	CbGeAlD
Acenocoumarol—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00172	0.00761	CcSEcCtD
Acenocoumarol—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00171	0.00757	CcSEcCtD
Acenocoumarol—Skin exfoliation—Methotrexate—urinary bladder cancer	0.00169	0.00749	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.00166	0.00734	CcSEcCtD
Acenocoumarol—CYP3A4—renal system—urinary bladder cancer	0.00164	0.0194	CbGeAlD
Acenocoumarol—Ulcer—Doxorubicin—urinary bladder cancer	0.00163	0.00718	CcSEcCtD
Acenocoumarol—Melaena—Epirubicin—urinary bladder cancer	0.00162	0.00717	CcSEcCtD
Acenocoumarol—ALB—lymph node—urinary bladder cancer	0.00162	0.0191	CbGeAlD
Acenocoumarol—Neoplasm—Methotrexate—urinary bladder cancer	0.00161	0.00709	CcSEcCtD
Acenocoumarol—Skin exfoliation—Epirubicin—urinary bladder cancer	0.00159	0.00701	CcSEcCtD
Acenocoumarol—Alopecia—Gemcitabine—urinary bladder cancer	0.00154	0.00681	CcSEcCtD
Acenocoumarol—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00154	0.00679	CcSEcCtD
Acenocoumarol—Alopecia—Fluorouracil—urinary bladder cancer	0.00151	0.00669	CcSEcCtD
Acenocoumarol—Neoplasm—Epirubicin—urinary bladder cancer	0.0015	0.00664	CcSEcCtD
Acenocoumarol—Melaena—Doxorubicin—urinary bladder cancer	0.0015	0.00664	CcSEcCtD
Acenocoumarol—Skin exfoliation—Doxorubicin—urinary bladder cancer	0.00147	0.00649	CcSEcCtD
Acenocoumarol—Alopecia—Cisplatin—urinary bladder cancer	0.00144	0.00634	CcSEcCtD
Acenocoumarol—Neoplasm—Doxorubicin—urinary bladder cancer	0.00139	0.00614	CcSEcCtD
Acenocoumarol—CYP3A4—female reproductive system—urinary bladder cancer	0.00132	0.0155	CbGeAlD
Acenocoumarol—Alopecia—Etoposide—urinary bladder cancer	0.00132	0.00581	CcSEcCtD
Acenocoumarol—Decreased appetite—Thiotepa—urinary bladder cancer	0.00128	0.00565	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00127	0.00562	CcSEcCtD
Acenocoumarol—Urticaria—Thiotepa—urinary bladder cancer	0.00117	0.00517	CcSEcCtD
Acenocoumarol—Body temperature increased—Thiotepa—urinary bladder cancer	0.00116	0.00514	CcSEcCtD
Acenocoumarol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00108	0.00479	CcSEcCtD
Acenocoumarol—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00108	0.00476	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00107	0.00472	CcSEcCtD
Acenocoumarol—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00106	0.00468	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00105	0.00465	CcSEcCtD
Acenocoumarol—Diarrhoea—Thiotepa—urinary bladder cancer	0.00101	0.00445	CcSEcCtD
Acenocoumarol—Decreased appetite—Cisplatin—urinary bladder cancer	0.001	0.00443	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000996	0.0044	CcSEcCtD
Acenocoumarol—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000979	0.00433	CcSEcCtD
Acenocoumarol—Urticaria—Fluorouracil—urinary bladder cancer	0.000967	0.00427	CcSEcCtD
Acenocoumarol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000962	0.00425	CcSEcCtD
Acenocoumarol—Haematuria—Methotrexate—urinary bladder cancer	0.000947	0.00418	CcSEcCtD
Acenocoumarol—Vomiting—Thiotepa—urinary bladder cancer	0.000936	0.00414	CcSEcCtD
Acenocoumarol—Dermatitis—Thiotepa—urinary bladder cancer	0.000927	0.0041	CcSEcCtD
Acenocoumarol—Decreased appetite—Etoposide—urinary bladder cancer	0.000919	0.00406	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000913	0.00403	CcSEcCtD
Acenocoumarol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000912	0.00403	CcSEcCtD
Acenocoumarol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000897	0.00396	CcSEcCtD
Acenocoumarol—Haemoglobin—Methotrexate—urinary bladder cancer	0.000896	0.00396	CcSEcCtD
Acenocoumarol—Haemorrhage—Methotrexate—urinary bladder cancer	0.000892	0.00394	CcSEcCtD
Acenocoumarol—Haematuria—Epirubicin—urinary bladder cancer	0.000886	0.00392	CcSEcCtD
Acenocoumarol—Nausea—Thiotepa—urinary bladder cancer	0.000874	0.00386	CcSEcCtD
Acenocoumarol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00085	0.00376	CcSEcCtD
Acenocoumarol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000847	0.00374	CcSEcCtD
Acenocoumarol—Urticaria—Etoposide—urinary bladder cancer	0.00084	0.00371	CcSEcCtD
Acenocoumarol—Haemoglobin—Epirubicin—urinary bladder cancer	0.000839	0.00371	CcSEcCtD
Acenocoumarol—Body temperature increased—Etoposide—urinary bladder cancer	0.000836	0.00369	CcSEcCtD
Acenocoumarol—Haemorrhage—Epirubicin—urinary bladder cancer	0.000834	0.00369	CcSEcCtD
Acenocoumarol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000833	0.00368	CcSEcCtD
Acenocoumarol—Haematuria—Doxorubicin—urinary bladder cancer	0.00082	0.00362	CcSEcCtD
Acenocoumarol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00079	0.00349	CcSEcCtD
Acenocoumarol—Alopecia—Methotrexate—urinary bladder cancer	0.000788	0.00348	CcSEcCtD
Acenocoumarol—Vomiting—Gemcitabine—urinary bladder cancer	0.000787	0.00348	CcSEcCtD
Acenocoumarol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00078	0.00345	CcSEcCtD
Acenocoumarol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000779	0.00344	CcSEcCtD
Acenocoumarol—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000776	0.00343	CcSEcCtD
Acenocoumarol—Vomiting—Fluorouracil—urinary bladder cancer	0.000774	0.00342	CcSEcCtD
Acenocoumarol—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000772	0.00341	CcSEcCtD
Acenocoumarol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000767	0.00339	CcSEcCtD
Acenocoumarol—Alopecia—Epirubicin—urinary bladder cancer	0.000737	0.00326	CcSEcCtD
Acenocoumarol—Nausea—Gemcitabine—urinary bladder cancer	0.000736	0.00325	CcSEcCtD
Acenocoumarol—Vomiting—Cisplatin—urinary bladder cancer	0.000734	0.00324	CcSEcCtD
Acenocoumarol—Dermatitis—Cisplatin—urinary bladder cancer	0.000727	0.00321	CcSEcCtD
Acenocoumarol—Diarrhoea—Etoposide—urinary bladder cancer	0.000723	0.0032	CcSEcCtD
Acenocoumarol—Nausea—Fluorouracil—urinary bladder cancer	0.000723	0.0032	CcSEcCtD
Acenocoumarol—Nausea—Cisplatin—urinary bladder cancer	0.000686	0.00303	CcSEcCtD
Acenocoumarol—Alopecia—Doxorubicin—urinary bladder cancer	0.000682	0.00301	CcSEcCtD
Acenocoumarol—Vomiting—Etoposide—urinary bladder cancer	0.000672	0.00297	CcSEcCtD
Acenocoumarol—Dermatitis—Etoposide—urinary bladder cancer	0.000666	0.00294	CcSEcCtD
Acenocoumarol—Nausea—Etoposide—urinary bladder cancer	0.000628	0.00278	CcSEcCtD
Acenocoumarol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000551	0.00243	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000547	0.00242	CcSEcCtD
Acenocoumarol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000515	0.00228	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000512	0.00226	CcSEcCtD
Acenocoumarol—Urticaria—Methotrexate—urinary bladder cancer	0.000503	0.00222	CcSEcCtD
Acenocoumarol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000501	0.00221	CcSEcCtD
Acenocoumarol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000477	0.00211	CcSEcCtD
Acenocoumarol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000473	0.00209	CcSEcCtD
Acenocoumarol—Urticaria—Epirubicin—urinary bladder cancer	0.000471	0.00208	CcSEcCtD
Acenocoumarol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000469	0.00207	CcSEcCtD
Acenocoumarol—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000467	0.00206	CcSEcCtD
Acenocoumarol—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000437	0.00193	CcSEcCtD
Acenocoumarol—Urticaria—Doxorubicin—urinary bladder cancer	0.000436	0.00193	CcSEcCtD
Acenocoumarol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000434	0.00192	CcSEcCtD
Acenocoumarol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000433	0.00192	CcSEcCtD
Acenocoumarol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000406	0.00179	CcSEcCtD
Acenocoumarol—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000404	0.00179	CcSEcCtD
Acenocoumarol—Vomiting—Methotrexate—urinary bladder cancer	0.000403	0.00178	CcSEcCtD
Acenocoumarol—Dermatitis—Methotrexate—urinary bladder cancer	0.000399	0.00176	CcSEcCtD
Acenocoumarol—Vomiting—Epirubicin—urinary bladder cancer	0.000377	0.00167	CcSEcCtD
Acenocoumarol—Nausea—Methotrexate—urinary bladder cancer	0.000376	0.00166	CcSEcCtD
Acenocoumarol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000375	0.00166	CcSEcCtD
Acenocoumarol—Dermatitis—Epirubicin—urinary bladder cancer	0.000373	0.00165	CcSEcCtD
Acenocoumarol—Nausea—Epirubicin—urinary bladder cancer	0.000352	0.00156	CcSEcCtD
Acenocoumarol—Vomiting—Doxorubicin—urinary bladder cancer	0.000349	0.00154	CcSEcCtD
Acenocoumarol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000345	0.00153	CcSEcCtD
Acenocoumarol—Nausea—Doxorubicin—urinary bladder cancer	0.000326	0.00144	CcSEcCtD
Acenocoumarol—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000245	0.00255	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000245	0.00255	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000243	0.00253	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000237	0.00246	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000226	0.00236	CbGpPWpGaD
Acenocoumarol—VKORC1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000218	0.00227	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000218	0.00227	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000212	0.00221	CbGpPWpGaD
Acenocoumarol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000212	0.00221	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000211	0.0022	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000209	0.00218	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000207	0.00215	CbGpPWpGaD
Acenocoumarol—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000204	0.00212	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000202	0.0021	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000199	0.00207	CbGpPWpGaD
Acenocoumarol—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000195	0.00203	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000193	0.002	CbGpPWpGaD
Acenocoumarol—ALB—Platelet degranulation—IGF1—urinary bladder cancer	0.000188	0.00196	CbGpPWpGaD
Acenocoumarol—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000186	0.00193	CbGpPWpGaD
Acenocoumarol—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000179	0.00187	CbGpPWpGaD
Acenocoumarol—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	0.000179	0.00186	CbGpPWpGaD
Acenocoumarol—VKORC1—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000176	0.00183	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000175	0.00182	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.00017	0.00177	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.00017	0.00177	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—IL2—urinary bladder cancer	0.000169	0.00175	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00171	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000164	0.00171	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000162	0.00168	CbGpPWpGaD
Acenocoumarol—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000159	0.00165	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000157	0.00164	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000157	0.00164	CbGpPWpGaD
Acenocoumarol—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	0.000151	0.00157	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000148	0.00154	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000146	0.00152	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000146	0.00152	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000144	0.0015	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000144	0.0015	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000143	0.00149	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000141	0.00147	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000141	0.00147	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000137	0.00143	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000137	0.00143	CbGpPWpGaD
Acenocoumarol—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000135	0.0014	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000134	0.00139	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000133	0.00138	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000132	0.00137	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000131	0.00136	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000127	0.00132	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—TNF—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Acenocoumarol—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000123	0.00128	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000121	0.00126	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.00012	0.00125	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.00012	0.00125	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000119	0.00124	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000115	0.00119	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000115	0.00119	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.00119	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000114	0.00118	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000113	0.00117	CbGpPWpGaD
Acenocoumarol—ALB—Folate Metabolism—TP53—urinary bladder cancer	0.000108	0.00113	CbGpPWpGaD
Acenocoumarol—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00109	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000103	0.00108	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTZ1—urinary bladder cancer	9.99e-05	0.00104	CbGpPWpGaD
Acenocoumarol—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	9.75e-05	0.00101	CbGpPWpGaD
Acenocoumarol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.66e-05	0.00101	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTO2—urinary bladder cancer	9.47e-05	0.000986	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NAT1—urinary bladder cancer	9.47e-05	0.000986	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.32e-05	0.00097	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	8.97e-05	0.000934	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.81e-05	0.000916	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.69e-05	0.000904	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—UGT2B7—urinary bladder cancer	8.66e-05	0.000902	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	8.5e-05	0.000885	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NAT1—urinary bladder cancer	8.5e-05	0.000885	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.36e-05	0.00087	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	8.34e-05	0.000868	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	8.18e-05	0.000851	CbGpPWpGaD
Acenocoumarol—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	8.09e-05	0.000842	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.05e-05	0.000838	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.98e-05	0.000831	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CYP4B1—urinary bladder cancer	7.8e-05	0.000812	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	7.78e-05	0.000809	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NAT1—urinary bladder cancer	7.75e-05	0.000807	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	7.75e-05	0.000807	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	7.64e-05	0.000795	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.63e-05	0.000794	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IFNA2—urinary bladder cancer	7.44e-05	0.000774	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—SLC19A1—urinary bladder cancer	7.37e-05	0.000767	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PRSS3—urinary bladder cancer	7.18e-05	0.000747	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	7.09e-05	0.000738	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	7e-05	0.000729	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.99e-05	0.000727	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	6.63e-05	0.00069	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NAT1—urinary bladder cancer	6.63e-05	0.00069	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	6.61e-05	0.000688	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.52e-05	0.000678	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	6.45e-05	0.000671	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	6.41e-05	0.000667	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	6.39e-05	0.000664	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	6.06e-05	0.000631	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	6.03e-05	0.000628	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.88e-05	0.000612	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.76e-05	0.000599	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TYMP—urinary bladder cancer	5.74e-05	0.000597	CbGpPWpGaD
Acenocoumarol—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	5.59e-05	0.000582	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.51e-05	0.000574	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	5.46e-05	0.000568	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.39e-05	0.000561	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—PLAU—urinary bladder cancer	5.28e-05	0.000549	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NAT2—urinary bladder cancer	5.19e-05	0.00054	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.17e-05	0.000538	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	5.15e-05	0.000536	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TYMP—urinary bladder cancer	5.15e-05	0.000536	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.11e-05	0.000532	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.11e-05	0.000532	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	5.02e-05	0.000523	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.95e-05	0.000515	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.71e-05	0.00049	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.7e-05	0.000489	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.68e-05	0.000487	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.66e-05	0.000485	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.51e-05	0.00047	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—RRM2—urinary bladder cancer	4.48e-05	0.000466	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—CREBBP—urinary bladder cancer	4.35e-05	0.000453	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IGF1—urinary bladder cancer	4.3e-05	0.000447	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NAT2—urinary bladder cancer	4.25e-05	0.000442	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.21e-05	0.000438	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—HPGDS—urinary bladder cancer	4.15e-05	0.000432	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ENO2—urinary bladder cancer	4.15e-05	0.000432	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.13e-05	0.000429	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.03e-05	0.000419	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTT1—urinary bladder cancer	4.02e-05	0.000419	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.02e-05	0.000419	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.01e-05	0.000418	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.98e-05	0.000414	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.96e-05	0.000412	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—RHOA—urinary bladder cancer	3.94e-05	0.00041	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.88e-05	0.000403	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.86e-05	0.000401	CbGpPWpGaD
Acenocoumarol—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.77e-05	0.000392	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.73e-05	0.000388	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.73e-05	0.000388	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.7e-05	0.000385	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.67e-05	0.000382	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.63e-05	0.000378	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.61e-05	0.000376	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.56e-05	0.00037	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.4e-05	0.000353	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.4e-05	0.000353	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.38e-05	0.000351	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NQO1—urinary bladder cancer	3.34e-05	0.000348	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—IL2—urinary bladder cancer	3.3e-05	0.000344	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.000343	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.25e-05	0.000338	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.24e-05	0.000338	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.13e-05	0.000326	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.1e-05	0.000322	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3e-05	0.000312	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—EP300—urinary bladder cancer	2.96e-05	0.000309	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.91e-05	0.000303	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.9e-05	0.000302	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.9e-05	0.000302	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.89e-05	0.0003	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—SRC—urinary bladder cancer	2.88e-05	0.0003	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.83e-05	0.000295	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.82e-05	0.000293	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.8e-05	0.000292	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTP1—urinary bladder cancer	2.79e-05	0.00029	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.77e-05	0.000288	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.74e-05	0.000285	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.7e-05	0.000281	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.66e-05	0.000276	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—TYMS—urinary bladder cancer	2.59e-05	0.00027	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—NCOR1—urinary bladder cancer	2.56e-05	0.000267	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GSTM1—urinary bladder cancer	2.56e-05	0.000267	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.54e-05	0.000264	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.5e-05	0.000261	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—GPX1—urinary bladder cancer	2.46e-05	0.000255	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.42e-05	0.000252	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.42e-05	0.000252	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—ERCC2—urinary bladder cancer	2.41e-05	0.000251	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—KRAS—urinary bladder cancer	2.39e-05	0.000248	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.000243	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.33e-05	0.000242	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.32e-05	0.000241	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.3e-05	0.000239	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.3e-05	0.000239	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000238	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.27e-05	0.000236	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—MTHFR—urinary bladder cancer	2.27e-05	0.000236	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.24e-05	0.000233	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.24e-05	0.000233	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.21e-05	0.00023	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.2e-05	0.000229	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.17e-05	0.000226	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.16e-05	0.000225	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.000221	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—TP53—urinary bladder cancer	2.12e-05	0.000221	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000218	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000218	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.03e-05	0.000212	CbGpPWpGaD
Acenocoumarol—ALB—Hemostasis—HRAS—urinary bladder cancer	2.03e-05	0.000211	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.000209	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.98e-05	0.000206	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	0.000205	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.95e-05	0.000203	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.89e-05	0.000196	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000193	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PPARG—urinary bladder cancer	1.84e-05	0.000191	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.81e-05	0.000189	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.81e-05	0.000188	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.79e-05	0.000187	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.79e-05	0.000187	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—CREBBP—urinary bladder cancer	1.76e-05	0.000184	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000179	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000175	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.65e-05	0.000172	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.58e-05	0.000165	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.58e-05	0.000165	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.51e-05	0.000157	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000156	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.00015	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.4e-05	0.000146	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.38e-05	0.000144	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.38e-05	0.000144	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.33e-05	0.000138	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	0.000135	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.3e-05	0.000135	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000134	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—PTEN—urinary bladder cancer	1.26e-05	0.000131	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.23e-05	0.000128	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000127	CbGpPWpGaD
Acenocoumarol—ALB—Metabolism—EP300—urinary bladder cancer	1.2e-05	0.000125	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000123	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.13e-05	0.000118	CbGpPWpGaD
Acenocoumarol—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.08e-05	0.000112	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.000107	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000105	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.92e-06	0.000103	CbGpPWpGaD
Acenocoumarol—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.84e-06	0.000102	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	9.53e-06	9.91e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.82e-06	9.17e-05	CbGpPWpGaD
Acenocoumarol—CYP1A2—Metabolism—EP300—urinary bladder cancer	8.41e-06	8.75e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.8e-06	8.12e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.8e-06	7.08e-05	CbGpPWpGaD
Acenocoumarol—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.49e-06	6.75e-05	CbGpPWpGaD
